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OBJECTIVE: We sought to estimate what proportion of
adults plan to stop cancer screening tests among adults
who recently considered screening and to explore
factors associated with these screening plans.
DESIGN: Telephone Survey
PARTICIPANTS: A total of 1,237 participants aged 50
and older who reported having made one or more
cancer screening decisions in the past 2 years complet-
ed 1,454 cancer screening modules for breast, prostate
and colorectal screening.
MAIN RESULTS: Of all module respondents, 9.8%
reported plans to stop screening, 12.6% for breast,
6.0 % for prostate and 9.5% for colon cancer. We
found no statistically significant differences in plans
to stop for those ages≥70 (8.2%) compared to those
ages 50 to 69 (10.2%) (p=0.14.) Black respondents
were less likely to report plans to stop than white
respondents (OR=0.32, 95% CI 0.12, 0.87). Participa-
tion in the decision-making process was associated
with plans to stop screening; those who reported they
made the final decision about screening (OR 5.9, 95%
CI 1.4, 24.7) or made the decision with the health
care provider (OR 4.1, 95% CI 1.0, 16.8) were more
likely to have plans to stop screening compared to
respondents who reported that their health care
provider made the final decision.
CONCLUSIONS: Plans to stop screening were uncom-
mon among participants who had recently faced a
screening decision. Given the recent US Preventive
Services Task Force recommendations limiting routine
cancer screening for older adults, additional efforts to
educate adults about the potential risks and benefits of
screening may be warranted.
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INTRODUCTION
Cancer screening tests for breast, colorectal and prostate
cancers are used in an effort to decrease cancer specific
mortality. However, the benefits from screening for these
cancers may be delayed for 5 to 10 years 1–3. Given this delay,
those at advanced age or with multiple co-morbid conditions
are at risk of dying from other causes before they realize a
survival benefit from screening 4,5. Furthermore, individuals
who undergo screening tests put themselves at immediate risk
of having complications, either from the screening tests or
from subsequent evaluations because of a positive screening
test. Consequently, some guidelines for cancer screening
suggest stopping cancer screening in individuals with limited
life expectancy 6,7. Recently, the USPSTF made specific age-
related recommendations, recommending against prostate
screening for men aged 75 and older 2, and recommending
against routine screening for CRC screening after age 75 and
any CRC screening after age 85 8.
Despite these recommendations to stop, relatively little
attention has been directed to attitudes toward stopping or
continuing cancer screening tests as people age 9–11. The US
public’s expectations toward cancer screening have enormous
implications for resource use in the US as the population ages.
Prematurely stopping screening in those who could potentially
benefit could lead to underutilization of screening and result in
preventable deaths. On the other hand, continuing screening
with little potential benefit could result in overutilization and
the potential of net harm. Given the aging of the population in
the US, understanding perceptions about continuing or stop-
ping cancer screening tests is warranted to avoid mispercep-
tions of ageism and to target resources at those most likely to
benefit and least likely to be harmed.
In this study, we addressed the issue of stopping cancer
screening in a sample of adults aged 50 and older who had
previously undergone screening and reported having dis-
cussed cancer screening with their provider within the last 2
years or undergone screening within that time period. We
Some of the information in this manuscript was presented at the 31st
National Meeting of the Society of General Internal Medicine in
Pittsburgh, PA, April 9-12 2008.
Received March 20, 2009
Revised October 19, 2009
Accepted March 17, 2010
Published online April 21, 2010
859
sought to estimate what proportion of adults plan to stop
cancer screening tests for colorectal, prostate and breast
cancer among those who had recently faced decisions about
cancer screening and to explore factors associated with these
screening plans.
METHODS
The results reported in this paper are part of a larger study, the
National Survey of Medical Decisions (the DECISIONS study) 12.
The DECISIONS study used a list-assisted random-digit-dial
(RDD) telephone survey methodology. Full details of the sam-
pling, instrument development and data collection methodology
have been reported by Zikmund-Fisher et al. 12. All procedures
and instruments were approved by the University of Michigan
and the Ann Arbor Veterans’ Affairs Medical Center institutional
review boards.
PARTICIPANTS
The larger study included a national probability sample of
3,010 English-speaking US adults 40 years of age and older.
Recruitment efforts achieved a weighted cooperation rate of
86.5% of all individuals screened and confirmed by interviewers
as being eligible to participate and a weighted American Associ-
ation of Public Opinion Research RR4 response rate 13 of 51.6%.
These rates compare favorably to those obtained by many
surveys that use random digit dialing methodology, such as the
often cited Centers for Disease Control and Prevention’s Behav-
ioral Risk Factor Surveillance System (2006 median response
rate: 51.4%) 14–16 and reflect the growing difficulty of conducting
telephone surveys in the general population 17.
The sampling strategy for the larger study was designed to
assess the prevalence of medical decisions for nine common
medical decisions. Participants were recruited from a proba-
bility sample of households using random-digit-dial methods.
Details of the sampling strategy have been described in detail
elsewhere 18. Briefly, individual respondents, who had been
selected at random from all eligible adults aged 40 and older in
each household, were asked whether they had taken a
particular action for the nine common medical issues within
the last 2 years, and if not, whether they had discussed the
action with a provider in that time frame.
To be eligible for the cancer screening modules, respondents
had to have been screened in the past and therefore would have
the opportunity to consider stopping. Those who had been
previously diagnosed with the relevant cancer were excluded
from these modules. In addition, respondents were eligible to
complete a module if they reported having a screening test for
these cancers within the preceding 2 years or having discussed
doing so with a health care provider in that same time period.
Consequently, we identified people who had previously been
screened and had faced another decision about cancer screening
within the past 2 years. This sampling strategy targets partici-
pants in the active decision-making stage and excludes those
who had already decided to stop screening, and those who are up
to date with screening for CRC with tests such as colonoscopy
and therefore would not have had recent discussions.
For this paper, we restricted the sample to those 50 years old
and older because these respondents are eligible for cancer
screening. We report information from three targeted question
modules related to decision making about colorectal, breast or
prostate cancer screening. Because respondents were randomly
assigned to respond to up to two modules for which they were
eligible, some respondents answered two cancer screeningmodels.
QUESTIONNAIRE
Each module included questions about whether or not the
respondent had any plans to stop regular cancer screening. We
asked, “Do you plan to stop getting screening tests for colon
(breast or prostate) cancer at a certain age?” and (if yes) “At
what age will (did you) stop getting tested?” We also asked
participants questions about aspects of their discussions with
health care providers within the last 2 years regarding cancer
screening tests. In addition, all respondents answered a set of
questions about socio-demographic characteristics and their
perceptions of cancer risk.
ANALYSES
All analyses were adjusted for selection, non-response, post-
stratification and module-randomization weights 17. Combined,
these weights permit generalization to the population of adult
patients aged 50 and older who hadpreviously undergone each of





n = 1,454 n=556 n = 283 n=615
Age
Mean (SD) 62.4 (9.4) 62.2 (9.3) 61.7 (8.9) 62.8 (9.8)
50–69 % 76.8% 74.9% 81.5% 75.9%
70 and over % 23.2% 24.1% 18.5% 24.1%
Gender %




42.9% 52.4% 37.3% 38.8%
Some college 20.9% 18.2% 21.2% 22.5%
College graduate/
post-graduate
36.3% 29.3% 41.4% 38.7%
Race %
White 73.1% 74.6% 78.9% 69.5%
Black 17.8% 18.6% 11.4% 20.2%
Other 9.1% 6.9% 9.7% 10.3%
Household income
<$25 K 17.5% 22.2% 10.2% 17.5%
$25 K–$49.9 K 27.2% 31.2% 26.8% 24.6%
$50 K–$74.9 K 21.3% 21.4% 19.8% 21.9%
$75 K–$99.9 K 13.1% 12.3% 13.4% 13.5%
$100 K+ 21.0% 12.9% 29.9% 22.5%
Insured %
Yes 95.3% 95.0% 95.4% 95.4%
Self-reported health
status %
Excellent-good 85.2% 85.5% 86.6% 84.4%
Fair/poor 14.8% 14.5% 13.4% 15.6%
Self-perceived risk
of cancer
Low risk 48.3% 50.6% 38.0% 51.5%
Medium risk 37.8% 31.9% 44.9% 38.6%
High risk 13.9% 17.5% 17.1% 9.9%
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the three types of cancer screening. We used SAS 9.13 survey
procedures (PROCSURVEYFREQand PROCSURVEYLOGISTIC)
to estimate population means, 95% confidence intervals and the
significance of differences in proportions while adjusting for this
weighting and stratification structure. Missing data on selected
demographic variables were imputed using sequential regression
imputation, implemented in IVEWare. 19,20 Only four demo-
graphic variables (race, education, insurance status and income
category) required imputation; missing data rates ranged from
0.14% for insurance status to 13.2% for income.
We initially report weighted frequencies for individual cancer
types separately. We then combined the different cancer types
and fit one multivariable model using logistic regression that
included all the respondent characteristics (Table 2) and all
aspects of discussions about cancer screening tests (Table 3),
and adjusted for the clustering arising from some respondents
answering more than one cancer screening module.
RESULTS
A total of 1,237 participants completed 1,454 cancer screening
modules (556 breast, 283 prostate and 615 colorectal). Two
hundred sixty participants responded to more than one
screening module; 156 women responded to both the colorec-
tal and breast cancer modules, and 104 men responded to the
colorectal and prostate cancer screening modules.
About one quarter (23%) of all the module respondents were
age 70 and over (Table 1). The majority were women (57%),
white (75%) and had health insurance (95%). Forty-three
percent reported having a high school education or less, and
15% reported fair to poor health.
PLANS TO STOP CANCER SCREENING
Overall 9.8% of module respondents reported having plans to
stop screening (Fig. 1). The proportion of module respondents
with plans to stop screening varied by cancer type. The
smallest proportion reporting plans to stop was men consider-
ing prostate cancer screening, 6.0%. For breast cancer screen-
ing, 12.6% of women had plans to stop and for colorectal
cancer screening, 9.5% of men and women reported plans to
stop. For module respondents aged 70 and older, 8.2%
reported plans to stop compared to 10.2% for those aged 50
to 69.
The proportion planning to stop screening for each cancer
differed by age when each cancer type was examined sepa-
rately. For breast cancer, 5.7% of women aged 70 and older
had plans to stop compared to 14.9% for women aged 50 to 69
Figure 1. Percent with plans to stop cancer screening among adults who recently considered screening.
Table 2. Unadjusted Percentages and Adjusted ORa for
Associations Between Respondent Characteristics and Plans to
Stop Cancer Screening for Any Cancer
Characteristics Plan to
stop %
OR 95% CI p value
Age p=0.25
50–69 10.2%





Some college 10.6% 1.33 0.67–2.63
College graduate or more 11.0% 1.46 0.82–2.61
Gender p=0.15
Women 11.6%
Men 7.4% 0.61 0.31–1.19
Race p=0.008
White 10.2%
Black 3.8% 0.32 0.12–0.87
Other 20.3% 2.63 1.04–6.65
Household income P=0.65
<$25 K 7.4% 1.00 0.35–2.85
$25 K–$49.9 K 9.5% 1.35 0.67–2.73
$50 K–$74.9 K 10.8% 1.25 0.62–2.53




No 8.7% 0.95 0.38–2.40
Health status
Excellent-good 9.9% p=0.74
Fair/poor 8.8% 1.13 0.56–2.27
Cancer risk beliefs p=0.11
Low risk 12.1%
Medium risk 8.6% 0.69 0.43–1.09
High risk 5.7% 0.44 0.17–1.14
aORs, CIs and p-values from multivariable logit model controlling for all
variables in Tables 2 and 3
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(difference 9.2%, 95% CI 3.1%, 15.4%). For prostate cancer,
0% of men aged 70 and older compared to 7.4% of men aged 50
to 69 reported plans to stop (difference 7.4%, 95% CI 3.5%,
11.3%). For colorectal cancer, 8.2% of those 70 and older
reported plans to stop compared to 10.2% of respondents aged
50 to 69 (difference 2.0%, 95% CI -2.1%, 6.1%).
Among the 153 respondents who reported plans to stop, 119
gave a specific stopping age. For breast cancer screening, the
mean stopping age was 74.8 (SD 10.0), and for colorectal and
prostate cancer screening, the mean stopping age was 76.8
(SD 11.6) and 82.9 (SD 8.4), respectively.
CHARACTERISTICS ASSOCIATED WITH PLANS
TO STOP CANCER SCREENING
We found that only one respondent characteristic was associ-
ated with having plans to stop cancer screening in the logistic
regression modeling that included both participant character-
istics (Table 2) and aspects of patient-provider discussions
(Table 3). Compared to white respondents, black respondents
were less likely to report plans to stop (OR=0.32, 95% CI 0.12,
0.87, p = 0.03), while those of other non-Caucasian races were
more likely to report plans to stop (OR = 2.63, 95% CI 1.04,
6.65, p = 0.04). The other respondent characteristics (age,
gender, insurance status, education, self-reported health
status, cancer risk and income) were not independently
associated with plans to stop screening for the three cancers
combined.
Among aspects of discussions with respondents’ health care
providers, two were independently associated with plans to
stop screening (Table 3) when we controlled for both respon-
dent characteristics and aspects of discussions. Respondents
who reported they made the final decision (OR 5.9, 95% CI 1.4,
24.7, p=0.02) and those who reported that they made the
decision with their health care providers (OR 4.1, 95% CI 1.0,
16.8, p=.05) were more likely to have plans to stop screening
compared to respondents who reported that their health care
providers made the final decision. Additionally, those who said
their health care providers explained the reasons for and
against screening “well” were less likely to have plans to stop
screening (OR=0.45, 95% CI 0.23, 0.90, p = 0.02).
DISCUSSION
Among a sample of adults aged 50 and older who had
previously undergone screening for breast, colon or prostate
cancer screening and had discussed screening with their
providers or undergone testing within the past 2 years, we
found that plans to stop screening were uncommon. A slightly
higher proportion of respondents reported plans to stop breast
cancer screening than prostate or colon cancer screening. A
smaller proportion of respondents aged 70 years old and older
reported plans to stop compared to those aged 50 to 69 years
old. We also found that black respondents were less likely to
report plans to stop screening than whites and that those of
other races were more likely to have plans to stop than whites.
Table 3. Unadjusted Percentages and Adjusted ORa for Associations Between Aspects of Discussions About Cancer Screening Tests and Plans
to Stop Cancer Screening for Any Cancer
Plan to stop % OR* 95% CI p value
Who first raised the idea of getting screening test? p=0.89
Patient 9.4% 0.96 0.54–1.72
Health care provider 9.9%
How much did health care provider discuss reasons to have a screening test? p=0.83
Not at all 12.2%
A little 8.1% 0.74 0.27–2.05
Some 10.5% 0.98 0.38–2.52
A lot 8.6% 0.95 0.37–2.43
How much did health care provider discuss reasons not to have a screening test? p=0.28
Not at all 9.3%
A little 10.9% 1.45 0.68–3.12
Some 13.8% 1.97 0.94–4.13
A lot 8.6% 1.06 0.37–3.02
Did health care provider express an opinion about whether or not you should have a
screening test?
p=0.18
Yes 9.9% 1.51 0.82–2.78
No 24.6%
Did the health care provider ask you what your preference was with regard to whether
or not to have a screening test?
p=0.48
Yes 9.4% 0.84 0.53–1.36
No 10.0%
Did the health care provider explain the reasons whether or not to have a screening
test in a way that you could understand?
Yes 9.0% 0.45 0.23–0.90 P=0.02
No 15.0%
Who made the final decision whether or not to have a screening test? p=0.03
Mainly my decision 12.5% 5.89 1.41–24.66
We made the decision together 8.7% 4.07 0.99–16.75
Mainly health care provider’s decision 2.2%
aORs, CIs and p-values from multivariable logit model controlling for all variables in Tables 2 and 3
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When we examined aspects of discussions about cancer
screening tests, we found that respondents who reported
receiving information about stopping from providers or who
did not participate in decision making about stopping were
less likely to have plans to stop screening.
Our findings that a small proportion of people who have
recently faced a decision about cancer screening report plans
to stop cancer screening are consistent with other research in
this area. One nationally representative survey found less than
one-third of people surveyed reported that they would stop
cancer screening 9. However, the question was posed hypo-
thetically to younger adults and therefore may not reflect older
adults’ actual perceptions. Another smaller study, from two
continuing care retirement communities, found similar results
in adults aged 70 and over. This study adds to these findings in
a larger sample of adults in the US who have either recently
been screened for breast, colon or prostate cancer or had
recent discussions with their health care providers.
Our analyses were notable because we did not find expected
associations between those with poorer health status or
increased age and plans to stop screening. It is important to
note that our sampling strategy excluded those who had
stopped cancer screening prior to our 2-year eligibility require-
ment. Therefore, among older individuals in poorer health,
those who may be reticent to stop screening were more likely to
be participants in our study. The decision process about
stopping cancer screening is particularly relevant for these
individuals because those who are older or in poorer health
status are those most likely to experience net harm 8. However,
these negative results should be interpreted with caution given
the small numbers, but suggest the need for further research
about cancer screening in older adults with poorer health
status.
As with respondent characteristics, we found few associa-
tions between aspects of discussions with providers and plans
to stop screening. Our findings suggest that the provider input
for people considering cancer screening, either by providing
information or in the decision process, is inversely associated
with plans to stop cancer screening. This suggests that
providers’ attitudes toward stopping cancer screening and
interactions between providers and patients could be an
important target for future research.
Although our study does not address why a small propor-
tion of respondents have plans to stop cancer screening,
previous work suggests that people may be unaware of the
delay in the benefit from screening and the need to consider life
expectancy 10. Given the new recommendations by the
USPSTF, it will be important to understand how patients
perceive the benefits and downsides of screening in the context
of limited life expectancy and determine whether further
education is needed. Resnick found that educating older
adults about the risks and benefits of screening resulted in
more realistic expectations about screening 21. However,
educating people about the complexities of screening may be
challenging, as demonstrated by experience with prostate
cancer screening 22–24.
Our study has several limitations. First, our sample was
limited to those who had recent contact with a health care
provider and may bias our results in favor of screening.
Although it is reassuring that our results are consistent with
previous studies 9–11, these studies may have similar biases.
On the other hand, our intent was to estimate the proportion of
people who have plans to stop screening in a population where
the decision-making process was active, as this population
would be a target to improve decision making. A different study
design would be needed to estimate the proportion of the
population who had already decided to stop cancer screening.
Given the exclusion of those who may have already stopped,
these results should not be construed to represent the overall
stopping rate among the US population. Another limitation
was that our survey questions have not been formally validat-
ed. However, we did perform cognitive interviews to help
ensure if respondents were interpreting the questions in the
manner we intended. Finally, the perceptions of the non-
respondents may differ significantly from those reported here.
Plans to stop screening were uncommon among partici-
pants who had recently faced a screening decision. Further
study is required to better understand how patients perceive
the benefits and downsides of screening in the context of
limited life expectancy. Given the recent US Preventive Services
Task Force recommendations either against or limiting routine
cancer screening for adults aged 75 and older, additional
efforts to educate adults about the importance of considering
the potential risks and benefits of screening may be warranted.
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